Dixon Hubard Feinour & Brown’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.18M Buy
4,854
+35
+0.7% +$8.58K 0.14% 136
2022
Q1
$1.17M Buy
4,819
+100
+2% +$23K 0.12% 155
2021
Q4
$1.06M Buy
4,719
+3,458
+274% +$730K 0.1% 152
2021
Q3
$268K Buy
1,261
+303
+32% +$69.7K 0.06% 156
2021
Q2
$234K Sell
958
-252
-21% -$62K 0.05% 172
2021
Q1
$308K Hold
1,210
0.04% 168
2020
Q4
$308K Hold
1,210
0.08% 132
2020
Q3
$308K Hold
1,210
0.08% 132
2020
Q2
$309K Sell
1,210
-66
-5% -$15.1K 0.08% 131
2020
Q1
$259K Sell
1,276
-115
-8% -$25.1K 0.09% 127
2019
Q4
$335K Buy
1,391
+300
+27% +$66.1K 0.09% 129
2019
Q3
$211K Sell
1,091
-6
-0.5% -$1.15K 0.06% 165
2019
Q2
$202K Sell
1,097
-119
-10% -$21.3K 0.06% 168
2019
Q1
$231K Buy
1,216
+131
+12% +$25K 0.07% 152
2018
Q4
$211K Hold
1,085
0.08% 145
2018
Q3
$225K Hold
1,085
0.06% 160
2018
Q2
$200K Buy
+1,085
New +$192K 0.06% 158
2017
Q4
Sell
-35,027
Closed -$6.53M 192
2017
Q3
$6.53M Buy
35,027
+132
+0.4% +$23.4K 1.87% 15
2017
Q2
$6.01M Buy
34,895
+180
+0.5% +$29.3K 1.74% 16
2017
Q1
$5.7M Sell
34,715
-25
-0.1% -$4.15K 1.69% 19
2016
Q4
$5.08M Sell
34,740
-1,960
-5% -$295K 1.61% 22
2016
Q3
$6.12M Buy
+36,700
New +$6.21M 1.9% 17

Other funds holding AMGN

Dixon Hubard Feinour & Brown's AMGN Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown increased its Amgen (AMGN) stake by 0.73% in Q2 2022, buying an estimated $8.58K and bringing the position to 4,854 shares worth $1.18M. The position accounts for 0.14% of the portfolio, ranked #136.

Dixon Hubard Feinour & Brown first reported a position in AMGN in Q3 2016 and has held it in 22 quarters since. The position peaked at $6.53M in Q3 2017. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Dixon Hubard Feinour & Brown held 4,854 shares of Amgen worth $1.18M as of Q2 2022.
  • Dixon Hubard Feinour & Brown bought 35 Amgen shares in Q2 2022, an estimated $8.58K.
  • Amgen made up 0.14% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #136 holding.
  • Dixon Hubard Feinour & Brown first reported a position in Amgen in Q3 2016 and has held it in 22 quarters since.
  • Dixon Hubard Feinour & Brown's Amgen position peaked at $6.53M in Q3 2017.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.